Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178259 | SCV000230306 | benign | not specified | 2015-04-24 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000355961 | SCV000460145 | benign | Arterial calcification, generalized, of infancy, 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
Illumina Laboratory Services, |
RCV000265863 | SCV000460146 | benign | Hypophosphatemic rickets, autosomal recessive, 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Labcorp Genetics |
RCV001515718 | SCV001723855 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000355961 | SCV001876028 | benign | Arterial calcification, generalized, of infancy, 1 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001659696 | SCV001876029 | benign | Hypopigmentation-punctate palmoplantar keratoderma syndrome | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000265863 | SCV001876030 | benign | Hypophosphatemic rickets, autosomal recessive, 2 | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002226648 | SCV002505495 | benign | Type 2 diabetes mellitus | criteria provided, single submitter | research | rs1044498 of ENPP1 is associated with type 2 diabetes mellitus and increased insulin resistance. It is also associated with calcification of coronary artery disease, increasing the chances of macrovascular complications in diabetes. | |
OMIM | RCV000014558 | SCV000034810 | risk factor | Insulin resistance, susceptibility to | 2016-08-15 | no assertion criteria provided | literature only | |
OMIM | RCV000033192 | SCV000057037 | risk factor | Obesity | 2006-12-01 | no assertion criteria provided | literature only | |
OMIM | RCV001255136 | SCV001431239 | risk factor | Diabetes mellitus type 2, susceptibility to | 2006-12-01 | no assertion criteria provided | literature only | |
Laboratory of Cyto- |
RCV001843453 | SCV002102818 | likely pathogenic | Hypophosphatemic rickets | 2022-03-07 | flagged submission | clinical testing | |
Prevention |
RCV004541005 | SCV004799261 | benign | ENPP1-related disorder | 2020-04-23 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |